Mongolia Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mongolia Healthcare Journal.

Press releases published on November 9, 2026

Nov. 9, 2026

Ocular Therapeutix™ Reports Third Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

Nov. 9, 2026

Atea Pharmaceuticals Secures Credit Facility for Up to $200 Million from Hercules Capital

Indeterminate GlobeNewswire

Nov. 9, 2026

Annovis Announces Closing of $21.0 Million Public Offering with 24% Contribution from the Board Chairman

Indeterminate GlobeNewswire

Nov. 9, 2026

Kamada Declares Cash Dividend of $0.14 Per Share; The Company Continues its Record-High Year

Indeterminate GlobeNewswire

Nov. 9, 2026

Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing

Indeterminate GlobeNewswire

Nov. 9, 2026

CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care

Indeterminate GlobeNewswire

Nov. 9, 2026

Tango Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights

Indeterminate GlobeNewswire

Nov. 9, 2026

BlossomHill Therapeutics Announces Outcome from the End-of-Phase 1 Meeting with the FDA and Pivotal Phase 2 Trial Design for OMNI-EGFR™ Inhibitor, BH-30643, in EGFR C797S-Positive NSCLC

Indeterminate GlobeNewswire

Nov. 9, 2026

Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended September 30, 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

Tiziana Life Sciences to Present at BIO-Europe 2026 and Host KOL Webcast

Indeterminate GlobeNewswire

Nov. 9, 2026

Can-Fite Reports Ten-Year Survival Milestone for Advanced Liver Cancer Patient from Phase II Namodenoson Study

Indeterminate GlobeNewswire

Nov. 9, 2026

Medicenna Presents ABILITY-1 Data at SITC 2026 Showing 40% ORR in Gastrointestinal Cancer Patients with Biomarker Enriched Tumors Resistant to Approved Therapies

Indeterminate GlobeNewswire

Nov. 9, 2026

LifeStance Health Group Announces Launch of Secondary Public Offering

Indeterminate GlobeNewswire

Nov. 9, 2026

Home Instead Gives Ferris Bueller’s Sister the Day Off She Never Got

Indeterminate GlobeNewswire

Nov. 9, 2026

Abeona Therapeutics® Reports Third Quarter 2026 Financial Results and ZEVASKYN® Commercial Progress

Indeterminate GlobeNewswire

Nov. 9, 2026

Abeona Therapeutics® Acquires Phase 3-Ready APT-1011, Now ABO-801, and Enters Into Agreement for $30 Million Private Placement

Indeterminate GlobeNewswire

Nov. 9, 2026

DeepLife and 3billion partner to discover small-molecule therapeutics against genetic modifier targets across multiple diseases

Indeterminate GlobeNewswire

Nov. 9, 2026

German Institute Apologizes for Nazi Psychiatry, Vindicates Citizens Commission on Human Rights International

Indeterminate GlobeNewswire

Nov. 9, 2026

Biodesix to Showcase MRD Strategy at the Association for Molecular Pathology (AMP) 2026 Annual Meeting

Indeterminate GlobeNewswire

Nov. 9, 2026

Edesa Biotech Announces Agreement with KYORIN Pharmaceutical to Develop and Commercialize Paridiprubart in Japan

Indeterminate GlobeNewswire